Prevalence of Factor V Leiden and Prothrombin Mutation G20210A in Patients with a History of Thrombotic Phenomena in Temuco, Araucanía Region
Contenido principal del artículo
Resumen
Thrombotic phenomena are multifactorial phenomena with both acquired and inherited factors. Factor V Leiden (FVL) and G20210A mutation of prothrombin (FIIG20210A) are the most studied inherited factors, with a prevalence that varies by population and race, high in Europe and almost nil in Asian countries. Information concerning the prevalence of these mutations in Chile is scarce. The aim of this study was to determine the prevalence of FVL and FII G20210A mutation in patients with a history of thrombotic events in the city of Temuco, Araucanía region. Genetic analysis for FVL Thrombophilia and FIIG20210A mutation was performed from January 2012 to December 2013.Three hundred thirty-three screenings by PCR in real time and the genotype of each mutation were determined and analyzed by Melting curve. We found an average prevalence of 2.28% for the FVL, whereas FIIG20210A mutation was 6.49%. No mutations were found in homozygous state. Both mutations are present in our population, it is therefore important to evaluate the risk associated with their presence in patients with a history of thrombotic events. In our specific population FII G20210A mutation is highly prevalent, thus genetic studies should be realized or requested.
Citas
Bauduer, F. & Lacombe, D. Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics. Mol. Genet. Metab., 86(1- 2):91-9, 2005.
Bertina, R. M.; Koeleman, B. P.; Koster, T.; Rosendaal, F. R.; Dirven, R. J.; de Ronde, H.; van der Velden, P. A. & Reitsma, P. H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369(6475):64-7, 1994.
Departamento de Estadísticas e Información en Salud (DEIS). Esperanza de vida al nacer (en años) por periodo y sexo. Chile, 1950-2025. Santiago, Ministerio de Salud, 2004. Disponible en: http:// deis.minsal.cl/deis/ev/esperanza_de_vida/index.asp Departamento de Estadísticas e Información en Salud (DEIS). Defunciones y Mortalidad por causas. Diez primeras causas de muerte. Chile 2000 a 2010. 2010. Disponible en: http://www.deis.cl/defunciones-ymortalidad-por-causas/
Francès, F.; Portolès, O.; Gabriel, F.; Corella, D.; Sorlí, J. V.; Sabater, A.; Alfonso, J. L. & Guillén, M. Factor V Leiden (G1691A) and prothrombin-G20210A alleles among patients with deep venous thrombosis and in the general population from. Rev. Med. Chile, 134(1):13-20, 2006.
Guzmán, N. & Salazar, L. A. Frecuency of prothrombotic risk factors in patiens with deep venous thrombosis and controls: Their implications for thrombophilia screnning in chilean subjects. Genet. Test. Mol. Biomarkers, 14(5):599-602, 2010.
Jadaon, M. M. Epidemiology of Prothrombin G20210A mutation in the mediterranean region. Mediterr. J. Hematol. Infect. Dis., 3(1):e2011054, 2011a.
Jadaon, M. M. Epidemiology of activated protein C resistance and factor V Leiden in the mediterranean region. Mediterr. J. Hematol. Infect. Dis., 3:e2011037, 2011b.
Palomo, I.; Pereira, J.; Alarcón, M.; Pinochet, C.; Vélez, M. T.; Hidalgo, P.; Skagerberg, K. & Poblete, F. Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis. Rev. Med. Chile, 133(12):1425-33, 2005.
Palomo, I.; Segovia, F.; Parra, D.; Alarcón, M. & Rojas, E. Low prevalence of factor V Leiden and the prothrombin G20210A mutation in a healthy population from the central-south region of Chile. Rev. Bras. Hematol. Hemoter., 31(3):143-6, 2009.
Poort, S. R.; Rossendaal, F. R.; Reistma, P. H. & Berttina, R. M. A common genetic variation in the 3´untranslated region of prothrombin gene is associated with elevated plasma prothrombin level and an increase in venous thrombosis. Blood, 88(10):3698-703, 1996.
Sottilotta, G.; Mammì, C.; Furiò, G.; Oriana, V.; Latella, C. & Trapani Lombardo, V. High incidence of factor V Leiden y prothrombin G20210A in healthy southern Italians. Clin. Appl. Thromb. Hemost., 15(3):356-9, 2009.
Srur, E.; Vargas, C.; Salas, S.; Parra, J.; Bianchi, V.; Mezzano, D.; Muñoz, D.; Vásquez, M. & Pacheco, E. Primary thrombophilia. Report of 93 cases and 12 asymptomatic relatives. Rev. Med. Chile, 132(12):1466-73, 2004.